202 related articles for article (PubMed ID: 9728336)
1. Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V; Matzner U; Hess B; Lüllmann-Rauch R; Coenen R; Hartmann D; D'Hooge R; DeDeyn P; Nagels G
J Inherit Metab Dis; 1998 Aug; 21(5):564-74. PubMed ID: 9728336
[TBL] [Abstract][Full Text] [Related]
2. Genetics of metachromatic leukodystrophy.
Gieselmann V; Kreysing J; von Figura K
Gene Ther; 1994; 1 Suppl 1():S87. PubMed ID: 8542433
[TBL] [Abstract][Full Text] [Related]
3. Advances in the molecular genetics of metachromatic leukodystrophy.
Gieselmann V; von Figura K
J Inherit Metab Dis; 1990; 13(4):560-71. PubMed ID: 1977956
[TBL] [Abstract][Full Text] [Related]
4. Metachromatic leukodystrophy: consequences of sulphatide accumulation.
Gieselmann V; Franken S; Klein D; Mansson JE; Sandhoff R; Lüllmann Rauch R; Hartmann D; Saravanan VP; De Deyn PP; D'Hooge R; Van Der Linden AM; Schaeren-Wiemers N
Acta Paediatr Suppl; 2003 Dec; 92(443):74-9; discussion 45. PubMed ID: 14989469
[TBL] [Abstract][Full Text] [Related]
5. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
Gieselmann V
Acta Paediatr; 2008 Apr; 97(457):15-21. PubMed ID: 18339182
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.
Hess B; Saftig P; Hartmann D; Coenen R; Lüllmann-Rauch R; Goebel HH; Evers M; von Figura K; D'Hooge R; Nagels G; De Deyn P; Peters C; Gieselmann V
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14821-6. PubMed ID: 8962139
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of metachromatic leukodystrophy.
Gieselmann V; Polten A; Kreysing J; von Figura K
J Inherit Metab Dis; 1994; 17(4):500-9. PubMed ID: 7967499
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy in metachromatic leukodystrophy.
Sevin C; Cartier-Lacave N; Aubourg P
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
[TBL] [Abstract][Full Text] [Related]
9. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
10. Metachromatic leukodystrophy: recent research developments.
Gieselmann V
J Child Neurol; 2003 Sep; 18(9):591-4. PubMed ID: 14572136
[TBL] [Abstract][Full Text] [Related]
11. Delay of myelin formation in arylsulphatase A-deficient mice.
Yaghootfam A; Gieselmann V; Eckhardt M
Eur J Neurosci; 2005 Feb; 21(3):711-20. PubMed ID: 15733089
[TBL] [Abstract][Full Text] [Related]
12. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.
Eckhardt M; Hedayati KK; Pitsch J; Lüllmann-Rauch R; Beck H; Fewou SN; Gieselmann V
J Neurosci; 2007 Aug; 27(34):9009-21. PubMed ID: 17715338
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of metachromatic leukodystrophy.
Gieselmann V; Polten A; Kreysing J; Kappler J; Fluharty A; von Figura K
Dev Neurosci; 1991; 13(4-5):222-7. PubMed ID: 1687778
[TBL] [Abstract][Full Text] [Related]
14. Pseudodeficiency of arylsulphatase A: strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms.
Leistner S; Young E; Meaney C; Winchester B
J Inherit Metab Dis; 1995; 18(6):710-6. PubMed ID: 8750609
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.
Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V
Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723
[TBL] [Abstract][Full Text] [Related]
16. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
[TBL] [Abstract][Full Text] [Related]
19. Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro.
Sangalli A; Taveggia C; Salviati A; Wrabetz L; Bordignon C; Severini GM
Hum Gene Ther; 1998 Sep; 9(14):2111-9. PubMed ID: 9759937
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
